**Question:** Which of the following short-acting selective beta-blocker drug is used in the management of arrhythmia: March 2010

**Core Concept:** Selective beta-blockers are a class of medications that target beta-adrenergic receptors, blocking the effects of adrenaline and noradrenaline. Arrhythmias are irregular heart rhythms that can be caused by various factors, including overactive sympathetic nervous system. Selective beta-blockers are often used to manage arrhythmias by reducing heart rate, cardiac output, and sympathetic nervous system activity.

**Why the Correct Answer is Right:** Amiodarone (Option D) is a highly effective antiarrhythmic drug used in the management of various types of arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. It is a broad-spectrum drug that targets multiple ion channels, inhibiting the re-entry mechanisms responsible for arrhythmias. Unlike other beta-blockers, amiodarone does not have significant beta-blocking activity. Its unique properties make it an effective treatment for arrhythmias.

**Why Each Wrong Option is Incorrect:**

A. Propranolol (Option C) is a selective beta-blocker with predominantly beta-1 blocking activity. While it may be used in the management of certain arrhythmias, its use is limited compared to amiodarone due to its lack of antiarrhythmic properties.

B. Atenolol (Option B) is another selective beta-blocker with predominantly beta-1 blocking activity. Similar to propranolol, its use is limited for arrhythmia management compared to amiodarone due to its lack of antiarrhythmic properties.

C. Metoprolol (Option A) is another selective beta-blocker with predominantly beta-1 blocking activity, similar to propranolol and atenolol. Its use in arrhythmia management is limited due to its lack of antiarrhythmic properties.

**Clinical Pearl:** In the management of arrhythmias, it is essential to consider the patient's specific type and severity of arrhythmia along with their comorbidities and risk factors. A selective beta-blocker like propranolol, atenolol, or metoprolol is often chosen over amiodarone due to their lower risk profile and fewer side effects. However, in severe or refractory arrhythmias, amiodarone may be considered as a last resort due to its broad-spectrum antiarrhythmic properties.